Martín-Hernán
F, Sánchez-Hernández JG, Cano J, Campo J, del Romero J. Oral cancer, HPV infection and evidence of sexual transmission. Med Oral Patol Oral Cir Bucal. 2013 May 1;18 (3):e439-44.
doi:10.4317/medoral.18419
http://dx.doi.org/doi:10.4317/medoral.18419
|
1. Marur S, D'Souza
G, Westra WH, Forastiere
AA. HPV- associated heck and neck cancer: a virus- related cancer epidemic. Lancet Oncol. 2010;11:781-9. |
|
|
|
|
|
2. Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L et al. HPV in oral squamous
cell carcinoma vs head and neck squamous
cell carcinoma biopsies: a meta-analysis (1988–2007). Ann Oncol. 2008;19:1681-90. |
|
|
|
|
|
3. Syrjänen S. The role of human papillomavirus infection in head and neck cancers. Ann Oncol. 2010; 21:
243-5. |
|
|
|
|
|
4. Ritchie JM, Smith EM, Summersgill KF,
Hoffman HT, Wang D, Klussmann JP, et al. Human Papillomavirus infection as a prognostic factor in
carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003;104:336-40. |
|
|
|
|
|
5. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et
al. Evidence for a causal asociation between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-20. |
|
|
|
|
|
6. Dayyani F, Etzel
CJ, Liu M, Ho CH, Lippman SM, Tsao
AS. Meta- Analysis of the impact of Human Papillomavirus
(HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head & Neck Oncology. 2010;2:15. |
|
|
|
|
|
7. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis,
1982-1997.OralSurg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:622-35. |
|
|
|
|
|
8. Gillison ML, D´Souza
G, Westra W, Sugar E, Xiao W, Begum A, et al.
Distinct risk factor profiles for human papillomavirus
type-16 positive and human papilomavirus type-16
negative head and neck cancers. J Natl Cancer Inst.
2008;100:407-20. |
|
|
|
|
|
9. Nguyen NP, Chi A, Nguyen LM, Ly BH, Karlsson
U, Vinh – Hung V. Human papillomavirus-associated
oropharyngeal cancer: a new clinical entity. QJM . 2010;103:229-36. |
|
|
|
|
|
10. Herrero R, Castellsagué
X, Pawlita M, Lissowska
J, Kee F, Balaram P, et
al. Human papillomavirus and oral cancer: the internacional agency for research on cancer multicenter
study. J Natl Cancer Inst. 2003;95:1772-83. |
|
|
|
|
|
11. D'Souza G, Zhang HH, D'Souza
WD, Meyer RR, Gillison ML. Moderate predictive
value of demographic and behavioral characteristics for a diagnosis of
HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol. 2010;46:100-4. |
|
|
|
|
|
12. Shiboski CH, Schmidt BL, Jordan RC.
Tongue and tonsil carcinoma. Increasing trends in the U.S population ages
20-44 years. Cancer. 2005;103:1843-9. |
|
|
|
|
|
13. Tachezy
R, Klozar J, Saláková M,
Smith E, Turek L, Betka
J, et al. HPV and other risk factors of oral cavity/oropharyngeal
cancer in the Czech Republic. Oral Dis. 2005;11:181-5. |
|
|
|
|
|
14. Chocolatewala NM, Chaturvedi
P. Role of human papiloma virus in the oral
carcinogenesis: An Indian perspective. J
Cancer Res Ther. 2009;5:71-7. |
|
|
|
|
|
15. Smith EM, Swarnavel S, Ritchie JM, Wang
D, Haugen TH, Turek LP. Prevalence of human papillomavirus in the oral cavity/oropharynx
in a large population of children and adolescents. Pediatr
Infect Dis J. 2007; 26:836-40. |
|
|
|
|
|
16. Weinberger PM, Yu Z, Haffty BG, Kowalski
D, Harigopal M, Brandsma
J, et al. Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal
cancers with favorable prognosis. J Clin Oncol. 2006;24:736-47. |
|
|
|
|
|
17. Ljubojević S. The human papillomavirus vaccines. Acta Dermatovenerol Croat.
2006;14:208. |
|
|
|
|
|
18. Kreimer
AR, Alberg AJ, Daniel R, Gravitt
PE, Viscidi R, Garrett ES, et al. Oral human papillomavirus infection in adults is associated with
sexual behavior and HIV serostatus. J Infect Dis. 2004;189:686-98. |
|
|
|
|
|
19. D'Souza G, Agrawal
Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with
prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263-9. |
|
|
|
|
|
20. D'Souza
G, Kreimer AR, Viscidi R,
Pawlita M, Fakhry C, Koch
WM, et al. Case-control study of human papillomavirus
and oropharyngeal cancer. N Engl
J Med. 2007; 356:1944-56. |
|
|
|
|
|
21. Brondani M. HPV, oral sex, and the risk
of oral cancer: food for thought. Spec Care Dentist. 2008;28:183-4. |
|
|
|
|
|
22. Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan'gina
O, et al. Sexual behaviours and the risk of head
and neck cancers: a pooled analysis in the International Head and Neck Cancer
Epidemiology (INHANCE) consortium. Int J Epidemiol. 2010;39:166-81. |
|
|
|
|
|
23. Forster A, Wardle J, Stephenson J, Waller
J. Passport to promiscuity or lifesaver: press coverage of HPV vaccination
and risky sexual behavior. J Health Commun. 2010;15:205-17. |
|
|
|
|
|
24. Sikora AG, Morris LG, Sturgis EM.
Bidirectional association of anogenital and oral
cavity/pharyngeal carcinomas in men. Arch Otolaryngol
Head Neck Surg. 2009;135:402-5. |
|
|
|
|
|
25. Acha-Sagredo
A, Ruesga MT, Aguirregaviria
JI, Aguirre Urizar JM. Infección por VPH y
carcinogénesis oral. Med Oral Patol Oral Cir Bucal.2010;15:e1-2 . |
|
|
|
|
|
26. Bosch FX, Lorincz A, Mu-oz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin
Pathol. 2002;55: 244-65. |
|
|
|
|
|
27. Licitra L, Perrone
F, Bossi P, Suardi S, Mariani L, Artusi R, et al.
High – risk papillomavirus affects prognosis in
patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24:5630-6. |
|
|
|
|
|
28. Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, et al.
EFGR, p16, HPV Titer, Bcl- xl and p53, sex and
smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008; 26: 3128-37. |
|
|
|
|
|
29. Fakhry C, Westra
WH, Li S, Cmelak A, Ridge JA, Pinto H, et al.
Improved survival of patients with human papillomavirus-
positive head and neck squamous cell carcinoma in a
prospective clinical trial. J Natl Cancer Inst.
2008;100: 261-9. |
|
|
|
|
|
30. Dahlstrom KR, Li G, Tortolero-Luna
G, Wei Q, Sturgis EM. Differences in history of sexual behavior between
patients with oropharyngeal squamous
cell carcinoma and patients with squamous cell
carcinoma at other head and neck sites. Head
Neck. 2011;33:847-55. |
|
|
|
|
|
31. Baden LR, Curfman GD, Morrissey S, Drazen JM. Human Papillomavirus
Vaccine- Opportunity and Challenge. N Engl J Med.
2007;356:1990-1. |
|
|
|
|
|
32. Medeiros
LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR. Efficacy of human papillomavirus
vaccines: a systematic quantitative review. Int J Gynecol Cancer. 2009; 19:1166-76. |
|
|
|
|
|
33. Schiller JT, Castellsagué X, Villa LL,
Hildesheim A. An update of prophylactic human papillomavirus
L1 virus-like particle vaccine clinical trial results. Vaccine. 2008; 26:53-61. |
|
|
|
|
|
34. Lugarini J, Maddalo
F. Results of a vaccination campaign against human papillomavirus
in the province of La Spezia, Liguria, Italy, March-December 2008. Euro Surveill. 2009;14. pii:
19342. |
|
|
|
|
|
35. Rethman MP, Carpenter W, Cohen EE,
Epstein J, Evans CA, Flaitz CM et al.
Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc.
2010;141:509-20. |
|